Lonza Group, CH0013841017

Lonza Group stock gained 1.8 percent on October 5

Published on 10/05/2026 at 19:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lonza Group stock was last at CHF 575.80 on SIX at 4:28 p.m. CEST on October 5, 2026. Half-year Core EBITDA rose 27.4 percent to CHF 1.2 billion.

Börsen-Editorial: Dunkler Monitor mit BIOTECH, CDMO und SIX SWISS Beschriftung und Kursdiagrammen
Lonza CH0013841017 Boersen Bildschirm BIOTECH CDMO SIX SWISS neutrale Charts Editorial Stil, Illustration mit AI erstellt.

Lonza Group (ISIN CH0013841017) was last at CHF 575.80 on SIX at 4:28 p.m. CEST on October 5, 2026, up 1.8 percent during the session. The move keeps the contract development and manufacturing organization close to its CHF 597.80 52-week high and puts its latest operating figures back at the center of the investment case.

Half-year growth supports margins

According to Yahoo Finance, Lonza reported CHF 3.4 billion in sales for the first half of 2026 on July 22, 2026. Constant-exchange-rate sales growth reached 16 percent versus the first half of 2025, while Core EBITDA increased 27.4 percent to CHF 1.2 billion.

The Core EBITDA margin reached 34.8 percent, an increase of 4.4 percentage points from the first half of 2025. Free cash flow also rose to CHF 426 million from CHF 116 million, giving the earnings improvement a measurable cash-flow counterpart.

Guidance points to profitable growth

Lonza upgraded its full-year 2026 Core EBITDA margin outlook to 33%-34% from an outlook above 32%, according to Yahoo Finance. The company also reconfirmed its expectation for 11%-12% constant-exchange-rate sales growth in 2026.

The comparison between the first half and the full-year outlook matters because management expects a more normalized second half after the 16 percent first-half sales increase. Advanced Synthesis grew 27.7 percent in the first half, while its Core EBITDA margin reached 48.1 percent, a level management described as unusually high for the period.

Board change and capital plans

Lonza nominated Pearl Huang as an independent board member on September 30, 2026, subject to election at the May 2027 annual meeting, as reported by Financial Times. The nomination follows the planned departure of two long-serving board members after the next annual meeting.

Goldman Sachs maintained a Buy rating and a CHF 680 price target in a report dated October 1, 2026, according to Business Insider. That target lies 18.1 percent above the CHF 575.80 SIX price, keeping the valuation discussion tied to the companys upgraded margin outlook.

Stock remains below yearly high

Lonza Group stock was last at CHF 575.80 on SIX on October 5, 2026, with the intraday high at CHF 578.40 and 42,548 shares traded. The price stood 3.8 percent below the CHF 597.80 52-week high reached on August 25, 2026.

Lonza Group stock facts

  • Company: Lonza Group AG
  • ISIN: CH0013841017
  • Ticker: LONN
  • Trading venue: SIX Swiss Exchange
  • Price as of October 5, 2026, 4:28 p.m. CEST: CHF 575.80
  • Market capitalization: CHF 39.8 billion (as of October 5, 2026)
  • 52-week range: CHF 454.60-597.80 (as of October 5, 2026)
  • Sector / Industry: Healthcare / Biotechnology
  • Index membership: SMI

Upcoming dates for Lonza Group stock

  • October 13, 2026: Capital Markets Day at the Vacaville facility

More news and analyses on Lonza Group stock

Disclaimer...

en | CH0013841017 | LONZA GROUP | boerse | 70235688 | bgmi